No link between Covid vaccines used in India and heart attack risk: Study

Govt rubbishes reports on approval for Covaxin due to political pressure

50 mn doses of Covaxin set to expire early 2023 due to poor off take

DCGI nod to Bharat Biotech’s intranasal Covid vaccine for restricted emergency use

Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin

India supplied 23.9 crore COVID-19 vaccine doses to 101 countries, UN entities: Govt

Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech

NTAGI to review Covaxin, Corbevax data for 6-12 years Thursday, discuss reducing booster dose gap

Germany to recognize Covaxin for travel from June 1

Govt may not allow mixing of Covid vaccines for booster shots

Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old

70 pc people who took booster dose didn’t get Covid during 3rd wave in India Study

Covaxin gets DCGI nod for 6-12 age group, Corbevax approved for 5-12 bracket

Vaccine fatigue? Complacency confusion fear behind reluctance to take Covid booster says experts

In first quantitative sero-survey in Mumbai, 99.93 pc participants found with COVID-19 antibodies

No impact of WHO action on Covaxin, have not supplied to any UN agency: Bharat Biotech

ICMR study has shown rise in antibodies post Covaxin booster dose: MoS Health tells RS

Each dose of Covishield, Covaxin likely to be capped at Rs 275 after getting regular market approval

Bharat Biotech says Covaxin safe for booster dose against Covid

Guidelines on Covaxin for under 18 don’t mention EUL by WHO: Health Ministry

Mix & Match of Covaxin, Covishield elicits 4 times antibody response, says study

For now, Covaxin likely to be only Covid vaccine available for children of 15-18 yrs

Will be under 14-day observation after home isolation restrictions lifted: Recovered Omicron patient

Experts allay Covaxin concerns, say 50 pc effectiveness against Delta-driven Covid surge not bad

Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment: Lancet study

India-made Covaxin now on UK’s approved travel list

If citizen loses job due to vaccine administered, is state not duty-bound to redress it? Kerala HC poser to Centre

Inactivated virus vaccine Covaxin has cellular immune memory to Covid for at least six months: NII

How monkeys were tracked for Covaxin trial!

Covaxin 77.8% effective against COVID-19: Lancet study

Ideal time for booster dose for COVID vaccine is 6 months after 2nd dose: Bharat Biotech MD

Respite for Indian travellers as UK to add Covaxin to approved list from November 22

WHO grants emergency use listing to Bharat Biotech’s Covaxin

Covaxin gets shelf life extension up to 12 months

Latest Additions

Mudigere: “Modi hawa no more, It’s time for change”

Inmates can’t sign docs political in nature: DG (prisons) amid row over Kejriwal issuing orders

Mangaluru roadshow memorable, Mysuru public meeting phenomenal: Modi

Former Australia cricketer Michael Slater remanded in police custody for assault and stalking

SC notice to ED on Arvind Kejriwal’s plea against arrest in money laundering case

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.